Accuron MedTech Group, the largest medical device maker in Southeast Asia, officially opened the new $10 million Technology Centre located in Tuas on Thursday, 13 September. The 22,000 square foot (sq ft) center provides incubator facilities and business services for Accuron MedTech’s highly innovative, category-disrupting portfolio companies, which are complementary to its core urology business. Located next to the global headquarters of AMT, Accuron MedTech’s portfolio companies will be able to access AMT’s 44,000 sq ft of advanced manufacturing capabilities, such as rapid prototyping, turnkey manufacturing, clean-room manufacturing and assembly, 3D printing, and medical device sterilization.
On top of manufacturing support, companies can also tap into critical commercialization support resources such as R&D, finance, HR, and business development and have access to Accuron MedTech’s senior management team.
Beh Kian Teik, Assistant Managing Director of Singapore Economic Development Board, said, “The Technology Centre is an important undertaking that brings together the deep engineering and design capabilities of a large corporate such as Accuron MedTech, with the agility of startups to enable the development of new solutions for regional and global healthcare needs from Singapore.”
Renal company AWAK Technologies is the first portfolio company to move its headquarters to the new center. As a development-stage company, it has access to the center’s clean room manufacturing and assembly facility to support its research, development, manufacturing, and commercial activities. As more companies move to the Technology Centre, there is potential to expand the available space by 50 percent.
Announcing the launch of the Technology Centre, Communications and Information Minister S. Iswaran said, “In 2016, the MedTech manufacturing sector in Singapore generated a total output of more than S$11.5 billion and hired nearly 14,000 employees. The government has identified MedTech as a key sector in the biomedical sciences industry for development.” “Our vibrant and growing MedTech ecosystem, we believe, puts us in a good stance to unlock the rich opportunities that are in the regional and global markets.”